Suven Life Sciences Ltd

About [ edit ]

Suven Life Sciences is engaged in clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.

  • Market Cap 1,066 Cr.
  • Current Price 83.8
  • High / Low 109 / 19.4
  • Stock P/E
  • Book Value 9.20
  • Dividend Yield 1.19 %
  • ROCE -54.4 %
  • ROE -49.5 %
  • Face Value 1.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 9.11 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -52.48% over past five years.
  • Company has a low return on equity of -0.22% for last 3 years.
  • Debtor days have increased from 34.98 to 65.65 days.
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
192 90 2 2 2 1 3 9 1 9 2
146 79 22 51 43 22 30 34 16 27 28
Operating Profit 45 10 -20 -48 -42 -21 -28 -25 -14 -18 -27
OPM % 24% 11% -936% -2,025% -2,635% -1,517% -999% -290% -993% -196% -1,762%
Other Income 8 7 7 6 3 2 6 3 3 2 2
Interest 1 1 0 0 0 0 0 0 0 0 0
Depreciation 6 6 1 1 1 1 1 1 1 1 1
Profit before tax 47 11 -14 -44 -40 -20 -23 -23 -13 -17 -26
Tax % 45% 64% -3% 9% 35% 2% -0% -9% 19% 6% 7%
Net Profit 26 4 -14 -39 -26 -20 -23 -26 -10 -16 -24
EPS in Rs 2.04 0.30 -1.13 -3.10 -2.04 -1.56 -1.79 -2.01 -0.82 -1.23 -1.92
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
88 112 117 521 499 543 625 286 13 21
77 96 105 361 398 414 427 300 128 104
Operating Profit 11 16 13 159 102 129 198 -14 -116 -83
OPM % 13% 15% 11% 31% 20% 24% 32% -5% -917% -406%
Other Income 1 1 3 9 19 21 23 27 14 9
Interest 2 3 5 5 6 6 5 2 1 1
Depreciation 3 4 4 12 18 21 21 11 4 4
Profit before tax 6 11 6 152 98 123 196 0 -106 -79
Tax % 2% -5% -32% 28% 26% 29% 37% 15,038% 11%
Net Profit 6 11 8 109 72 87 124 -24 -94 -76
EPS in Rs 0.98 0.72 8.54 5.64 6.85 9.72 -1.88 -7.40 -5.98
Dividend Payout % 39% 26% 35% 7% 35% 15% 15% -80% 0%
Compounded Sales Growth
10 Years:%
5 Years:-52%
3 Years:-71%
TTM:153%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:30%
Stock Price CAGR
10 Years:52%
5 Years:44%
3 Years:87%
1 Year:57%
Return on Equity
10 Years:%
5 Years:5%
3 Years:-0%
Last Year:-50%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
5 6 12 13 13 13 13 13 13 13
Reserves 85 96 95 547 583 654 755 226 131 104
Borrowings 24 41 55 109 83 71 34 3 6 4
29 30 38 105 74 78 118 62 33 21
Total Liabilities 143 173 199 773 751 816 919 303 182 142
83 96 110 172 305 306 308 22 25 22
CWIP 3 5 4 107 7 10 25 0 0 3
Investments 4 5 2 0 0 301 279 223 0 5
53 68 83 494 439 199 308 58 157 112
Total Assets 143 173 199 773 751 816 919 303 182 142

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
5 16 4 143 68 109 70 -53 -194
-9 -20 -16 -110 -39 -311 -1 30 206
3 13 6 179 -68 -30 -52 5 3
Net Cash Flow -1 8 -7 212 -39 -232 17 -18 14

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2006 Mar 2007 Mar 2008 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 11% 8% 13% 15% 24% -4% -54%
Debtor Days 62 53 111 28 39 31 36 3 66
Inventory Turnover 2.14 2.22 2.37 2.08 1.63 1.29

Shareholding Pattern

Numbers in percentages

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00 60.00
2.50 4.41 5.83 6.07 5.67 4.71 4.02 4.29 3.95 1.57 1.02 1.05
4.85 2.28 2.08 2.41 2.48 3.10 3.39 3.73 0.86 0.78 0.67 0.67
32.65 33.31 32.09 31.52 31.85 32.19 32.59 31.98 35.19 37.65 38.31 38.28

Documents

Add document